Delivery Order SPE2DR25D3501-SPE2DR26FL9FK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,107.97 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,037.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, awarded on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a non-competed delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $28,904.13 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. The contract, which was not set aside and competitively awarded, has an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.07 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 28, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a $45,056.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vivitrol 380 mg vial-diluents. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and was awarded competitively without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9FKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,293.12 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Vivitrol, an extended-release naltrexone formulation, is used in medication-assisted treatment programs, and this delivery order reflects the company's role in supplying specialized pharmaceutical commodities across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 11/23/25 |